Dr. Swapna Goday, MD MPH

Dr. Goday is board certified in Hematology and Oncology with several years of clinical experience. She has a passion for patients with breast cancer and also treats all other solid tumors (GI, GU, lung, prostate), bleeding and clotting disorders, and malignant hematology. Having served as the Medical Director for an AntiCoagulation clinic, she also developed a special interest in benign hematology. Dr. Goday has participated in multiple clinical trials at the national level and is a member of the American College of Physicians, the American Society of Hematology, the American Society of Clinical Oncology, and the Texas Medical Association.

Dr. Goday is extremely happy to be a part of the Choice Cancer Care team and believes in the multidisciplinary approach that our team provides. She provides compassionate care for the patients and their families during the most difficult times and helps navigate them with the best treatment course possible. Communication with patients and their families and involving them in the decision-making process helps her tailor the best treatment approach for their diagnosis. This communication is key in managing the oncology care of cancer patients with complex medical issues. Dr. Goday collaborates closely with patients and their referring physicians when coordinating care and corresponds with them directly on her cell phone.

Outside of work, Dr. Goday loves to spend time with her husband and two sons who keep her very busy. She also enjoys traveling, running, baking, and volunteering for community activities. Dr.Goday is fluent in English, Hindi, and Telugu and is currently accepting new patients.

Summary

• Board certified in Hematology and Oncology with 7+ years of clinical experience.
• Focused interest in Solid tumors (Breast, GI, GU), Hemostasis & Thrombosis, Malignant
  Hematology.
• Active Texas Medical License.

Professional Experience & Academic Appointments

Education

Board Certification

• Board Certified in Medical Oncology, October 2012
• Board Certified in Hematology, October 2012
• American Board of Internal Medicine Certified, Sept. 2009
• ECFMG Certification, Feb. 2005

Medical Licensure

• Texas Medical License, Active, R2342
• California Medical License, Inactive, MD147639
• Pennsylvania Medical License, Inactive, MD437716
• Federal DEA, Active

Honors and Awards

• CALGB Summer Group Meeting, 2011 Travel Grant, Boston, MA June 2011
• Novo-Nordisk Fellowship Grant: HTRS (Hemophilia and Thrombosis Research Society)
  Coagulation Disorders Workshop, Orlando, Florida December 2, 2010
• Novo-Nordisk Fellowship Grant: HTRS (Hemophilia and Thrombosis Research Society)
  Coagulation Disorders Workshop, Diagnosis and Management of Coagulation Disorders
  on April 21, 2009, at San Diego, California.
• Gold Medal in Microbiology in 2000 for outstanding performance.
• First Division Honors in Medical school
• First Division in Pharmacology, Microbiology, Pathology, Forensic Medicine, ENT,
  Ophthalmology, Gynecology and Obstetrics, Medicine and Pediatrics in MBBS.
• Received certificate of Merit awarded by the Ministry of Human Resources &
  Development, Government of India as a part of National Scholarship Scheme in 1997-98

Additional Appointments

Committee Memberships

Professional Society Memberships

• Texas Medical Association
• American Society of Hematology, Associate Member
• American Society of Clinical Oncology, Associate Member
• Member of International Society on Thrombosis and Hemostasis (ISTH)
• American College of Physicians
• American Medical Association
• MPH Student Association ETSU Alumni

Presentations

• Hepatocellular carcinoma presenting as an atrial mass; S. Goday., A. Achilleos, K. Foust,
  C. Herb - Western Pennsylvania ACP Chapter Scientific Meeting Nov. 8, 2008.
• Pseudoaneurysm of the Superior Gluteal Artery occurring as a complication of Bone
  marrow Biopsy; A. Sinha, S. Goday, A. Achilleos - Western Pennsylvania ACP Chapter
  Scientific Meeting Nov. 8, 2008.
• EBV infection masquerading as Behcet’s disease; S. Goday, R. Volosky, A. Achilleos -
  Western Pennsylvania ACP Chapter Scientific Meeting Nov. 8, 2008.
• Spinal Neurosarcoidosis; S. Goday, A. Achilleos, S. Komerally, R. Arora- Western
  Pennsylvania ACP Chapter Scientific Meeting Nov. 8, 2008.
• Clinical Vignette Presentation, May 15, 2009 - Spinal Neurosarcoidosis at Society of
  General Internal Medicine (SGIM) at Florida.
• Medical Jeopardy Competition – Participant in ACP Medical Jeopardy Pennsylvania
  Chapter Scientific Meeting, Dec. 2008.

Research

• Co-Investigator: Discovery of targetable somatic alterations in drug resistant Triple
  Negative Breast Cancer after Neoadjuvant chemotherapy-UT Southwestern Medical
  Center, 2018-19
• Co-Investigator: S1207 :Phase III Randomized ,Placebo –Controlled Clinical Trial
  Evaluating the Use of Adjuvant Endocrine Therapy +/- One year of Everolimus in Patients
  with High Risk Hormone Receptor Positive and Her2/neu Negative Breast Cancer-UT
  Southwestern Medical Center, 2018-19.
• Co-Investigator: NSABP B-51 A Randomized Phase III Clinical Trial Evaluating Post
  Mastectomy Chest Wall and Regional Nodal XRT and Post Lumpecomy Regional Nodal
  XRT and Post Lumpectomy Regional Nodal XRT in patients with Positive Axillary Nodes
  before Neoadjuvant Chemotherapy who convert to Pathologically Negative Axillary
  Nodes After Neoadjuvant Chemotherapy- UT Southwestern Medical Center, 2018-19.
• Co-Investigator: Tailor RT A Randomized Trial of Regional Radiotherapy in Biomarker
  Low Risk Node Positive Breast Cancer - UT Southwestern Medical Center, 2018-19.
• Co-Investigator: A Phase 3 Randomized Study of Margetuximab Plus Chemotherapy vs
  transtuzumab Plus Chemotherapy in the Treatment of Patients with HER2 positive
  Metastatic Breast Cancer who have received prior Anti Her2 therapies and Require
  Systemic Treatment- UT Southwestern Medical Center, 2018-19.
• Co-Investigator: Pre Surgical trial of Letrozole in Post-Menopausal Patients with
  Operable Hormone Sensitive Breast Cancer- UT Southwestern Medical Center, 2018-19.
• Co-Investigator: MonarchE: Protocol 13 Y-MC-JPCF: A Randomized Open Label ,Phase3
  Study of Abemaciclib Combined with Standard Adjuvant Endocrine Therapy versus
  Standard Adjuvant Endocrine Therapy Alone in Patients with High Risk Node Positive, Early Stage Hormone Receptor positive ,Her2 Negative Breast Cancer - UT Southwestern Medical Center, 2018-19.
• Co-Investigator: EA1131 : A Randomized Phase III Post Operative Trial of Platinum Based
  Chemotherapy vs Capecitabine in patients with Residual Triple Negative Breast cancer
  following Neoadjuvant Chemotherapy- UT Southwestern Medical Center, 2018-19.
• Co-Investigator: A011106 :ALTernate approaches for clinical Stage II or III Estrogen
  Receptor positive Breast Cancer NeoAdjuvant Treatment( ALTERNATE) in postmenopausal
  women .A Phase III Study- UT Southwestern Medical Center, 2018-19.
• Co-Investigator: Comparison of Operative to Monitoring and Endocrine Therapy
  (COMET) Trial for Low Risk DCIS : A Phase III Prospective Randomized Trial -UT
  Southwestern Medical Center, 2018-19.
• Co-Investigator: A Phase III Randomized Double blind Study to Evaluate Pembrolizumab
  Plus Chemotherapy vs Placebo plus Chemotherapy as Neoadjuvant therapy and
  Pembrolizumab vs Placebo as Adjuvant Therapy For Triple Negative Breast Cancer.
  UT Southwestern Medical Center, 2018-19.
• Site Principal Investigator : ATTRACT Study ( NIH Funded) in colloboration with
  Washington University School of Medicine: Acute Venous Thrombosis –Thrombus
  removal with adjunctive catheter directed Thrombolysis .Final results published in NEJM
  -Dec 2017.
• Site Principal Investigator: BRIDGE Study ( NIH ,National Heart ,lung and Blood Institute
  funded) in colloboraton with Duke Clinical Research Institute :Bridging Anticoagulation
  in patients who require temporary interruption of warfarin therapy for an elective
  invasive procedure or therapy-Final results published in NEJM – August 2015.
• Site Principal Investigator: Comparison of Oral anticoagulants for extended VEnous
  Thromboembolism (COVET) in collaboration with Duke Clinical Research Institute
  Principal Investigator: Thomas Ortel, MD Co-Principal Investigator: Lana Castellucci, MD
  Co-Principal Investigator: David Garcia, MD.
• Co-Investigator:Alliance Venous Thromboembolism-Clincal Trial–Direct Oral
  Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer (CANVAS)-A
  Randomized Effectiveness Trial.
• Principal Investigator: Retrospective analysis of indications of IVC filter placement at
  Allegheny Health Network –Presented at local chapter –PSOH (Pennsylvania Soceity of
  Oncology and Hematology).

Publications

• Pharmacomechanical Catheter-Directed Thrombolysis for Deep-Vein Thrombosis
  Suresh Vedantham, MD etal. ATTRACT investigators. N Engl J Med. Dec 7, 2017
  ;377:2240-2252.
• Using Smartphones to Access Medical Reference Information.
  Swapna Goday MD, MPH Onc Live, Published September 12, 2011.
• An extremely rare case of pancreatic cancer presenting with leptomeningeal
  carcinomatosis and synchronous intraparenchymal brain metastasis.
  Gastrointestinal Cancer Research 2013 May-Jun; 6(3): 90–92 Rohit rao, Santosh K
  Sadashiv, Swapna Goday, Dulabh Monga.
• Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation
  Douketis JD, Spyropoulos AC, Kaatz S, Becker RC, Caprini JA, Dunn AS, Garcia DA, Jacobson
  A, Jaffer AK, Kong DF, Schulman S, Turpie AG, Hasselblad V, Ortel TL; BRIDGE
  Investigators. N Engl J Med. 2015 Aug 27;373(9):823-33.